Text Module


Share

Program Content

Activities

  • Role of the MDM2-p53 Pathway in BTC
    Targeting the MDM2-p53 Pathway in Biliary Tract Cancer: Emerging Data and Implications for Future Clinical Practice
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 29, 2024

    Expires: February 28, 2025

Faculty

cover img faculity

Patricia LoRusso, DO, PhD(h)

Associate Center Director, Experimental Therapeutics
Director, Early Phase Clinical Trials Program
Yale Cancer Center
Yale University
New Haven, Connecticut

cover img faculity

David N. Neubauer, MD

Associate Professor
Department of Psychiatry and Behavioral Sciences
Johns Hopkins University School of Medicine
Baltimore, Maryland

cover img faculity

Steven Christopher Smith, MD, PhD

Associate Professor of Pathology and Surgery
Director, Genitourinary and Soft Tissue Pathology
VCU School of Medicine and Massey Comprehensive Cancer Center
Richmond, Virginia

cover img faculity

Chetasi Talati, MD

Assistant Professor
Department of Oncologic Sciences
Assistant Member
Malignant Hematology
Moffitt Cancer Center
University of South Florida
Tampa, Florida

PT Faculty

cover img faculity

Michael K. Gibson, MD, PhD, FACP

Associate Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.